MAP3K7 and Miyoshi myopathy: To test whether TAK1-inhibitors also had an anti-MM effect in vivo we treated Vk*MYC MM mice with two different concentrations of the TAK1- inhibitor 5Z-7-oxozeaenol (5Z-7) and four different concentrations of the TAK1-inhibitor NG25.